Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haining Lusheng Pharmaceutical Technology is a pharmaceutical research and development company that operates as part of the Lusheng Pharma group. Headquartered in Haining, China, with affiliated R&D operations in Shanghai, the company specializes in the discovery and development of innovative small molecule drugs and high-end generic medications. Its therapeutic focus includes oncology, cardiovascular diseases, and metabolic disorders such as diabetes. In addition to its internal drug discovery programs, the company provides Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services, including the synthesis of complex pharmaceutical intermediates. Lusheng Pharmaceutical leverages its expertise in process chemistry and organic synthesis to support the entire drug development lifecycle from lead optimization to commercial production. The company is situated in the Haining Juanhu Lake International Science and Technology Park, benefiting from a robust regional biotech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haining Lusheng Pharmaceutical Technology.